- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
ACE2 polymorphisms impact COVID-19 severity in obese patients ; volume:12 ; number:1 ; day:13 ; month:12 ; year:2022 ; pages:1-13 ; date:12.2022
Scientific reports ; 12, Heft 1 (13.12.2022), 1-13, 12.2022
- Urheber
-
Jalaleddine, Nour
Bouzid, Amal
Hachim, Mahmood
Sharif-Askari, Narjes Saheb
Mahboub, Bassam
Senok, Abiola
Halwani, Rabih
Hamoudi, Rifat A.
Heialy, Saba Al
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-26072-7
- URN
-
urn:nbn:de:101:1-2023022220595709604705
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jalaleddine, Nour
- Bouzid, Amal
- Hachim, Mahmood
- Sharif-Askari, Narjes Saheb
- Mahboub, Bassam
- Senok, Abiola
- Halwani, Rabih
- Hamoudi, Rifat A.
- Heialy, Saba Al
- SpringerLink (Online service)
Ähnliche Objekte (12)
COVID-19 susceptibility: potential of ACE2 polymorphisms
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
The association of ACE1, ACE2, TMPRSS2, IFITM3 and VDR polymorphisms with COVID-19 severity : A systematic review and meta-analysis
Association between SUMF1 polymorphisms and COVID-19 severity
Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity
Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity
Comparative ACE2 variation and primate COVID-19 risk
ACE2, a drug target for COVID-19 treatment?
COVID-19 susceptibility: potential of ACE2 polymorphisms
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
The association of ACE1, ACE2, TMPRSS2, IFITM3 and VDR polymorphisms with COVID-19 severity : A systematic review and meta-analysis
Association between SUMF1 polymorphisms and COVID-19 severity
Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity
Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity
Comparative ACE2 variation and primate COVID-19 risk
ACE2, a drug target for COVID-19 treatment?
COVID-19 susceptibility: potential of ACE2 polymorphisms
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
The association of ACE1, ACE2, TMPRSS2, IFITM3 and VDR polymorphisms with COVID-19 severity : A systematic review and meta-analysis
Association between SUMF1 polymorphisms and COVID-19 severity
Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity
Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity
Comparative ACE2 variation and primate COVID-19 risk